American Medical Technologies Inc. (ADLI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 24, 2026
ADLI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | 2003 - 1999 |
|---|---|---|---|---|---|---|
Period Ending | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | 2003 - 1999 |
| Revenue | 2.5 | 3.19 | 2.76 | 2.16 | 2.26 | Upgrade
|
| Revenue Growth (YoY) | -21.51% | 15.49% | 27.86% | -4.21% | -24.75% | Upgrade
|
| Cost of Revenue | 0.85 | 1.49 | 1.4 | 1.42 | 1.2 | Upgrade
|
| Gross Profit | 1.66 | 1.7 | 1.36 | 0.74 | 1.06 | Upgrade
|
| Selling, General & Admin | 2.12 | 2.85 | 2.43 | 2.2 | 2.69 | Upgrade
|
| Research & Development | - | 0.02 | 0.07 | 0.18 | 0.15 | Upgrade
|
| Operating Expenses | 2.12 | 2.86 | 2.5 | 2.39 | 2.85 | Upgrade
|
| Operating Income | -0.46 | -1.16 | -1.14 | -1.65 | -1.79 | Upgrade
|
| Interest Expense | -0.04 | -0.05 | -0.11 | -0.11 | -0.12 | Upgrade
|
| Interest & Investment Income | - | 0.01 | 0.05 | 0.04 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.38 | 0.24 | 0.08 | 0.09 | 0.14 | Upgrade
|
| EBT Excluding Unusual Items | -0.12 | -0.97 | -1.12 | -1.62 | -1.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | 0.02 | 0.01 | -0.01 | 1.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.5 | 0.08 | - | 0.09 | - | Upgrade
|
| Legal Settlements | - | - | -0.43 | - | 0.1 | Upgrade
|
| Other Unusual Items | -0.2 | -0.05 | 0.15 | - | 0.14 | Upgrade
|
| Pretax Income | 0.19 | -0.93 | -1.38 | -1.54 | 0.03 | Upgrade
|
| Net Income | 0.19 | -0.93 | -1.38 | -1.54 | 0.03 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0.03 | 0.04 | 0.04 | 0.09 | Upgrade
|
| Net Income to Common | 0.19 | -0.95 | -1.42 | -1.58 | -0.06 | Upgrade
|
| Net Income Growth | - | - | - | - | -45.08% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 9 | 8 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 9 | 8 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | 18.79% | 5.99% | - | 2.61% | 5.95% | Upgrade
|
| EPS (Basic) | 0.02 | -0.11 | -0.17 | -0.19 | -0.01 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.11 | -0.17 | -0.19 | -0.01 | Upgrade
|
| Free Cash Flow | -0.17 | -0.39 | -1.53 | -1.58 | -3.48 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.19 | -0.19 | -0.44 | Upgrade
|
| Gross Margin | 66.12% | 53.24% | 49.23% | 34.11% | 46.92% | Upgrade
|
| Operating Margin | -18.51% | -36.48% | -41.21% | -76.25% | -79.19% | Upgrade
|
| Profit Margin | 7.76% | -29.86% | -51.46% | -73.32% | -2.58% | Upgrade
|
| Free Cash Flow Margin | -6.60% | -12.14% | -55.36% | -72.96% | -154.12% | Upgrade
|
| EBITDA | -0.26 | -0.96 | -1 | -1.54 | -1.68 | Upgrade
|
| EBITDA Margin | -10.42% | -30.20% | -36.06% | -71.45% | -74.40% | Upgrade
|
| D&A For EBITDA | 0.2 | 0.2 | 0.14 | 0.1 | 0.11 | Upgrade
|
| EBIT | -0.46 | -1.16 | -1.14 | -1.65 | -1.79 | Upgrade
|
| EBIT Margin | -18.51% | -36.48% | -41.21% | -76.25% | -79.19% | Upgrade
|
| Revenue as Reported | 2.5 | 3.19 | 2.76 | 2.16 | 2.26 | Upgrade
|
| Advertising Expenses | 0 | 0.03 | 0.02 | 0.04 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.